The Exchange had sought clarification from Aptech Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is enclosed.
APTECHT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 0.9 pts more than its Education peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The NSE had asked Aptech Limited to clarify why its Q4 FY25 financial results were not signed by an authorized signatory (Managing Director or Whole-time Director). The company responded that as on the date of filing, it did not have a Managing Director or Whole-time Director in place, so the results were signed by a Non-Executive Director. It cited Regulation 33(2)(b) of SEBI LODR, which permits any director duly authorized by the Board to sign results in the absence of MD/WTD. Mr. Rajiv Agarwal was authorized by the Board on May 8, 2025 to sign the financial results.
This is a procedural compliance clarification rather than a penalty or adverse action. It does highlight governance concerns, as Aptech currently lacks a Managing Director or Whole-time Director, which investors should monitor for leadership stability.